Amarin to Report Second Quarter 2014 Results and Host Conference Call on August 7, 2014 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report Second Quarter 2014 Results and Host Conference Call on August 7, 2014
Amarin Announces Notification of Patent Allowances for U.S. Applications 13/685,281, and 13/685,291 Related to Triglyceride Lowering With a Mixture of Omega-3 Free Fatty Acid (Including EPA and/or DHA) in Both the MARINE and ANCHOR Patient Populations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Notification of Patent Allowances for U.S. Applications 13/685,281, and 13/685,291 Related to Triglyceride Lowering With a Mixture of Omega-3 Free Fatty Acid (Including EPA and/or DHA) in Both the MARINE and ANCHOR Patient Populations
Amarin Announces Leadership Changes Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Leadership Changes
Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Receives FDA Notification That Action on ANCHOR sNDA Review Will be Delayed
Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed
Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales
Amarin to Present at the 2014 Leerink Global Healthcare Conference Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Present at the 2014 Leerink Global Healthcare Conference
Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules
Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014
